Rekord LOINC: 76545-3
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
76545-3
FHIR
|
| Long Common Name: | Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna |
| Short Name: | Brst ca 10Y dist recur class Prosigna |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
EN
Oryginalna wersja angielska
Breast cancer 10Y risk of distant recurrence classification
:
Imp
:
Pt
:
^Patient
:
Ord
:
Prosigna
Klasyfikacja
| Class: |
ENMOLPATH
|
| Consumer Name: | - |
| Order/Observation: | Observation |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | - |
| UCUM Units: | - |
| Version Last Changed: | 2.73 |
Definicja i opis
EN
The risk classification is an ordinal risk category (low, intermediate, high) that indicates a patient's risk of recurrence of breast cancer at 10 years. The classification is based on the 10-year risk of distant recurrence score and lymph node status. Low risk is associated with a 3% chance (confidence interval 2-6%), intermediate risk is associated with a 10% chance (confidence interval 7-14%), and high risk with a 16% chance (confidence interval 11-22%) of distant breast cancer recurrence at 10 years, respectively. [PMID: 24347518] This term was created for the Prosigna™ Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR+) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone.
Powiązane nazwy
breast cancer; Brst ca 10Y risk dist recur class; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Ordinal; PAM50; Point in time; Prosigna; Psoriasis Care Satisfaction questionnaire; Ql; Qual; Qualitative; Random; Screen